CD8A and non-small cell lung carcinoma: Next, we applied MGPfact to two populations of tumor-associated CD8+ T cells from non-small cell lung cancer (NSCLC)(Guo et al., 2018) and colorectal cancer (CRC) (Zhang et al., 2018), respectively.